RegisterLogin

ACHN-975 (TFA)

CAT: 0804-HY-19936A-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-19936A-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ACHN-975 TFA is a selective LpxC inhibitor and exhibits a subnanomolar LpxC inhibitory activity. ACHN-975 TFA is against a wide range of gram-negative bacterias with low MIC values (≤1 μg/mL) [1].
CAS Number
[1410809-37-8]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/achn-975-tfa.html
Purity
99.02
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N[C@H](C(NO)=O)C(C)(N)C)C1=CC=C(C#CC#C[C@H]2[C@H](CO)C2)C=C1.O=C(O)C(F)(F)F
Molecular Formula
C22H24F3N3O6
Molecular Weight
483.44
Precautions
H302, H315, H319, H335
References & Citations
[1]Kalinin DV, et al. Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor Design. Curr Top Med Chem. 2016;16 (21) :2379-430.|[2]Krause KM, et al. Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa.Antimicrob Agents Chemother. 2019 Oct 22;63 (11) . pii: e00977-19.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 1

Related Products

CatalogName
HY-19936ACHN-975
HY-138565-01K-975
HY-19844ANA-975
HY-16149SDZ-CPI 975
HY-P5766A-01AChRα (97-116) (TFA)
HY-P3460A-01TDSRCVIGLYHPPLQVY (TFA)
HY-P5229A-01IHRIC (TFA)
HY-P1149A-01Epitalon (TFA)
HY-P0205B-01Saralasin (TFA)
HY-P3333A-01KSPWFTTL (TFA)

Alternative Products

CatalogName
BUP23099ACHN-975 TFA
T10236L-01ACHN-975
TRC-A189820-25MGACHN 975
A20637-10ACHN-975 10mg
A20637-50ACHN-975 50mg
A20637-1ACHN-975 1mg
A20637-100ACHN-975 100mg
A20637-5ACHN-975 5mg
A20637-25ACHN-975 25mg
ARC0043ACHN

Popular Products